×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SONN – sonnet biotherapeutics holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SONN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/12
09:15 am
sonn
Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment
Medium
Report
Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment
11/6
01:20 pm
sonn
Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
High
Report
Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
11/6
08:30 am
sonn
Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates
High
Report
Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates
10/17
11:19 am
sonn
Sonnet BioTherapeutics regains compliance with Nasdaq [Seeking Alpha]
Low
Report
Sonnet BioTherapeutics regains compliance with Nasdaq [Seeking Alpha]
10/17
08:47 am
sonn
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq [Yahoo! Finance]
High
Report
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq [Yahoo! Finance]
10/17
08:45 am
sonn
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
High
Report
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
10/9
08:45 am
sonn
Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
Neutral
Report
Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
10/4
08:30 am
sonn
Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs
Low
Report
Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/8
08:31 am
sonn
Form 8-K Sonnet BioTherapeutics For: Nov 06
Medium
Report
Form 8-K Sonnet BioTherapeutics For: Nov 06
11/7
09:23 am
sonn
Form 424B4 Sonnet BioTherapeutics
Medium
Report
Form 424B4 Sonnet BioTherapeutics
11/7
06:03 am
sonn
Form EFFECT Sonnet BioTherapeutics
Medium
Report
Form EFFECT Sonnet BioTherapeutics
11/6
09:23 am
sonn
Form S-1/A Sonnet BioTherapeutics
High
Report
Form S-1/A Sonnet BioTherapeutics
11/6
08:49 am
sonn
Form 8-K Sonnet BioTherapeutics For: Nov 06
High
Report
Form 8-K Sonnet BioTherapeutics For: Nov 06
11/4
09:02 am
sonn
Form S-1/A Sonnet BioTherapeutics
Medium
Report
Form S-1/A Sonnet BioTherapeutics
10/28
09:01 am
sonn
Form S-1 Sonnet BioTherapeutics
High
Report
Form S-1 Sonnet BioTherapeutics
10/17
08:51 am
sonn
Form 8-K Sonnet BioTherapeutics For: Oct 16
Low
Report
Form 8-K Sonnet BioTherapeutics For: Oct 16
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
4/2
RELIEF THERAPEUTICS Holding SA Announces the Closing of its Share Exchange Agreement with Sonnet BioTherapeutics, Inc. for the Divestment of its wholly-owned Subsidiary Relief Therapeutics SA
-32.7%
4/22 Form 10-K/A Sonnet BioTherapeutics For: Dec 31 -11.7%
4/20 Form 8-K Sonnet BioTherapeutics For: Apr 16 -5.7%
4/10 Form SC 13G Sonnet BioTherapeutics Filed by: Altium Capital Management LP -3.3%
4/22 Form 10-K/A Sonnet BioTherapeutics For: Dec 31 -11.7%
4/20 Form 8-K Sonnet BioTherapeutics For: Apr 16 -5.7%
4/10 Form SC 13G Sonnet BioTherapeutics Filed by: Altium Capital Management LP -3.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: